Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced enrollment of the first participants in...
Maxim Reshetnikov visited the Biokhimik plant as part of acquaintance with the participants of the national project «Increasing labor productivity and supporting employment» which...
The R&D centre is tasked to optimise its substance manufacturing process and develop new unique molecules.
The complex has modern and high-precision equipment that allows...
Crohn's disease and ulcerative colitis are severe chronic bowel diseases for which there are no effective drugs yet. The main approach in their therapy...
Joint-stock company “Grindeks” has invested 800 thousand euros in the site of production of active pharmaceutical ingredients (APIs) and installed new, state-of-the-art laboratories and...